QuiVad

Home / Germany / Medigene AG

Medigene AG

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 2.74% on November 29, 2017. The shaded band matches the twelve months of the first chart.

December 1, 2016 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Medigene AG by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

109 disclosures on record for this share.
DateFund% of capitalEnd of publication
April 2, 2019GSA Capital Partners LLP0.48%
March 8, 2019GSA Capital Partners LLP0.59%
February 20, 2019GSA Capital Partners LLP0.68%
September 19, 2018GSA Capital Partners LLP0.70%
September 7, 2018GSA Capital Partners LLP0.62%
August 29, 2018GSA Capital Partners LLP0.50%
August 14, 2018Oxford Asset Management0.49%
August 13, 2018GSA Capital Partners LLP0.49%
August 1, 2018GSA Capital Partners LLP0.59%
July 25, 2018GSA Capital Partners LLP0.68%
July 17, 2018Oxford Asset Management0.59%
July 5, 2018GSA Capital Partners LLP0.70%
July 2, 2018Oxford Asset Management0.68%
June 26, 2018GSA Capital Partners LLP0.61%
June 19, 2018Oxford Asset Management0.79%
June 19, 2018GSA Capital Partners LLP0.58%
June 8, 2018Oxford Asset Management0.88%
May 28, 2018GSA Capital Partners LLP0.60%
May 25, 2018Oxford Asset Management0.93%
May 25, 2018GSA Capital Partners LLP0.59%
May 8, 2018GSA Capital Partners LLP0.68%
April 18, 2018GSA Capital Partners LLP0.70%
April 17, 2018Oxford Asset Management1.01%
April 6, 2018Oxford Asset Management0.90%
March 27, 2018GSA Capital Partners LLP0.69%
March 21, 2018Oxford Asset Management0.89%
March 7, 2018Oxford Asset Management0.90%
February 6, 2018Oxford Asset Management0.83%
February 6, 2018GSA Capital Partners LLP0.68%
January 24, 2018Citadel Advisors II LLC0.32%
January 23, 2018Oxford Asset Management0.79%
January 17, 2018Citadel Advisors II LLC0.58%
January 15, 2018Citadel Advisors II LLC0.69%
January 12, 2018Citadel Advisors II LLC0.78%
January 2, 2018Citadel Advisors II LLC0.82%
December 27, 2017Citadel Advisors II LLC0.79%
December 21, 2017Citadel Advisors II LLC0.80%
December 21, 2017GSA Capital Partners LLP0.70%
December 20, 2017Oxford Asset Management0.89%
December 14, 2017GSA Capital Partners LLP0.63%
December 12, 2017Citadel Advisors II LLC0.77%
December 11, 2017Oxford Asset Management0.91%
December 11, 2017Citadel Advisors II LLC0.64%
December 11, 2017Worldquant, LLC0.46%
December 8, 2017Citadel Advisors II LLC0.82%
December 8, 2017Worldquant, LLC0.52%
December 6, 2017Citadel Advisors II LLC0.94%
December 4, 2017Voleon Capital Management LP0.55%
December 4, 2017GSA Capital Partners LLP0.50%
December 1, 2017Citadel Advisors II LLC1.02%

Download 109 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Germany

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Medigene AG, source Bundesanzeiger, data as at April 2, 2019, https://www.quivad.com/action/medigene-ag